Matthew Baker
11Patents
6h-index
13Co-inventors
55Inventor score
Filing activity: Dec 14, 2000 → Jun 5, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6914137B2 | Isolation of nucleic acids | Chemistry; Metallurgy | 264 | Expired |
| US6670128B2 | Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7501113B2 | Aerosol formulations and aerosol delivery of buprenorphine | Human Necessities | 20 | Expired |
| US6718742B1 | Magnetic particle composition | Electricity | 13 | Expired |
| US7410635B2 | Aerosol formulations and aerosol delivery of scopolamine | Human Necessities | 12 | Expired |
| USD506829S1 | Plunger | General | 8 | Expired |
| US7319004B2 | Materials and methods relating to polyions and substance delivery | Human Necessities | 6 | Expired |
| US7893016B2 | Stabilisation of double-stranded nucleic acids using proteins | Chemistry; Metallurgy | 1 | Expired |
| US7244561B2 | Inhibiting denaturation of nucleic acid duplexes | Chemistry; Metallurgy | 1 | Expired |
| US9648857B2 | Methods of studying tolerance in MHC-II transgenic animals | Human Necessities | 0 | Active |
| US7501500B2 | Inhibiting denaturation of nucleic acid duplexes | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.